233 related articles for article (PubMed ID: 15718130)
1. Inhibiting protein-protein interactions using designed molecules.
Zhao L; Chmielewski J
Curr Opin Struct Biol; 2005 Feb; 15(1):31-4. PubMed ID: 15718130
[TBL] [Abstract][Full Text] [Related]
2. Engineering novel binding proteins from nonimmunoglobulin domains.
Binz HK; Amstutz P; Plückthun A
Nat Biotechnol; 2005 Oct; 23(10):1257-68. PubMed ID: 16211069
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
White AW; Westwell AD; Brahemi G
Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
[TBL] [Abstract][Full Text] [Related]
4. Protein-protein interactions as targets for small molecule drug discovery.
Fry DC
Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein-protein interactions using designed molecules.
Wilson AJ
Chem Soc Rev; 2009 Dec; 38(12):3289-300. PubMed ID: 20449049
[TBL] [Abstract][Full Text] [Related]
6. Modulation of biomolecular interactions with complex-binding small molecules.
Cai Z; Greene MI; Berezov A
Methods; 2008 Sep; 46(1):39-46. PubMed ID: 18571508
[TBL] [Abstract][Full Text] [Related]
7. The molecular architecture of protein-protein binding sites.
Reichmann D; Rahat O; Cohen M; Neuvirth H; Schreiber G
Curr Opin Struct Biol; 2007 Feb; 17(1):67-76. PubMed ID: 17239579
[TBL] [Abstract][Full Text] [Related]
8. Domain-based small molecule binding site annotation.
Snyder KA; Feldman HJ; Dumontier M; Salama JJ; Hogue CW
BMC Bioinformatics; 2006 Mar; 7():152. PubMed ID: 16545112
[TBL] [Abstract][Full Text] [Related]
9. Incorporating receptor flexibility in the molecular design of protein interfaces.
Li L; Liang S; Pilcher MM; Meroueh SO
Protein Eng Des Sel; 2009 Sep; 22(9):575-86. PubMed ID: 19643976
[TBL] [Abstract][Full Text] [Related]
10. Making protein interactions druggable: targeting PDZ domains.
Dev KK
Nat Rev Drug Discov; 2004 Dec; 3(12):1047-56. PubMed ID: 15573103
[TBL] [Abstract][Full Text] [Related]
11. Disruption of protein-protein interactions: towards new targets for chemotherapy.
Loregian A; Palù G
J Cell Physiol; 2005 Sep; 204(3):750-62. PubMed ID: 15880642
[TBL] [Abstract][Full Text] [Related]
12. A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design.
Card GL; Blasdel L; England BP; Zhang C; Suzuki Y; Gillette S; Fong D; Ibrahim PN; Artis DR; Bollag G; Milburn MV; Kim SH; Schlessinger J; Zhang KY
Nat Biotechnol; 2005 Feb; 23(2):201-7. PubMed ID: 15685167
[TBL] [Abstract][Full Text] [Related]
13. Strategies for targeting protein-protein interactions with synthetic agents.
Yin H; Hamilton AD
Angew Chem Int Ed Engl; 2005 Jul; 44(27):4130-63. PubMed ID: 15954154
[TBL] [Abstract][Full Text] [Related]
14. NMR studies of protein interactions.
Takeuchi K; Wagner G
Curr Opin Struct Biol; 2006 Feb; 16(1):109-17. PubMed ID: 16427776
[TBL] [Abstract][Full Text] [Related]
15. Emerging classes of protein-protein interaction inhibitors and new tools for their development.
Pagliaro L; Felding J; Audouze K; Nielsen SJ; Terry RB; Krog-Jensen C; Butcher S
Curr Opin Chem Biol; 2004 Aug; 8(4):442-9. PubMed ID: 15288255
[TBL] [Abstract][Full Text] [Related]
16. A new school for screening.
Jhoti H
Nat Biotechnol; 2005 Feb; 23(2):184-6. PubMed ID: 15696146
[No Abstract] [Full Text] [Related]
17. Therapeutic peptides: technological advances driving peptides into development.
Sato AK; Viswanathan M; Kent RB; Wood CR
Curr Opin Biotechnol; 2006 Dec; 17(6):638-42. PubMed ID: 17049837
[TBL] [Abstract][Full Text] [Related]
18. In vivo selection of intrabodies specifically targeting protein-protein interactions: a general platform for an "undruggable" class of disease targets.
Visintin M; Melchionna T; Cannistraci I; Cattaneo A
J Biotechnol; 2008 May; 135(1):1-15. PubMed ID: 18395925
[TBL] [Abstract][Full Text] [Related]
19. Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
Watt PM
Nat Biotechnol; 2006 Feb; 24(2):177-83. PubMed ID: 16465163
[TBL] [Abstract][Full Text] [Related]
20. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
